Grigorios Siokas, the CEO of Cosmos Health Inc. (NASDAQ:COSM), has purchased 55,732 shares of the company’s stock for a total of $35,111.16 in a transaction dated November 25, 2023. The shares were acquired at an average price of $0.63 per share, increasing Siokas’ total ownership in the company to 6,383,625 shares, which is now valued at approximately $4,021,683.75. This acquisition marks a 0.88% increase in his stake in Cosmos Health.
The details of this transaction were disclosed in a legal filing with the Securities and Exchange Commission (SEC). Siokas’ recent investment comes at a time when Cosmos Health’s stock is experiencing fluctuations, having increased by 2.1% to trade at $0.64 during midday trading on November 26, 2023. On that day, a total of 644,960 shares exchanged hands, surpassing the average volume of 611,960 shares.
Stock Performance and Analyst Ratings
Over the past year, Cosmos Health’s shares have seen a low of $0.28 and a high of $1.32. Currently, the company has a market capitalization of $22.38 million, a price-to-earnings (P/E) ratio of -0.85, and a beta of 5.32. The company’s financial ratios include a debt-to-equity ratio of 0.25, a current ratio of 0.99, and a quick ratio of 0.84.
Recent reports from various analysts indicate a cautious outlook for Cosmos Health. Wall Street Zen upgraded the stock to a “hold” rating on September 20, 2023, while Weiss Ratings reaffirmed a “sell (d-)” rating on October 8, 2023. Currently, the consensus rating for the stock is classified as “sell” based on data from MarketBeat.
Institutional Investments and Company Overview
In a notable development, Armistice Capital LLC increased its stake in Cosmos Health by 156.1% during the first quarter of this year. According to its latest 13F filing with the SEC, the hedge fund now owns 1,917,710 shares, worth approximately $836,000, after acquiring an additional 1,168,884 shares over the quarter. Institutional investors currently hold 12.61% of the company’s stock.
Cosmos Health Inc. specializes in the manufacture, development, and distribution of branded nutraceutical products across several countries, including Greece, the United Kingdom, Croatia, Bulgaria, the Cayman Islands, and Cyprus. The company offers a diverse range of products, such as medicines, over-the-counter medications, vitamins, and dietary health products, marketed under the Sky Premium Life and Mediterranation brand names.
For those interested in staying updated on Cosmos Health and similar companies, MarketBeat offers a free daily email newsletter summarizing the latest news and analysts’ ratings.
